stoxline Quote Chart Rank Option Currency Glossary
  
The Gabelli Healthcare & Wellness Trust (GRX)
9.1  -0.11 (-1.19%)    06-15 09:38
Open: 9.05
High: 9.1
Volume: 1,184
  
Pre. Close: 9.21
Low: 9.05
Market Cap: 137(M)
Technical analysis
2026-06-15 9:16:29 AM
Short term     
Mid term     
Targets 6-month :  10.79 1-year :  12.6
Resists First :  9.23 Second :  10.79
Pivot price 9.06
Supports First :  9 Second :  8.85
MAs MA(5) :  9.15 MA(20) :  9.03
MA(100) :  9.25 MA(250) :  9.11
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  90.5 D(3) :  87.8
RSI RSI(14): 61.4
52-week High :  9.86 Low :  8.45
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ GRX ] has closed below upper band by 7.7%. Bollinger Bands are 3.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.25 - 9.29 9.29 - 9.32
Low: 9.07 - 9.12 9.12 - 9.16
Close: 9.14 - 9.21 9.21 - 9.27
Company Description

The Gabelli Healthcare & Wellness Trust operates as a closed-ended equity fund, originally established by GAMCO Investors, Inc. Gabelli Funds, LLC serves as its investment manager. This fund's mandate is to invest globally in public equities, with a predominant focus on companies operating within the healthcare and wellness sectors. It considers businesses irrespective of their market capitalization, investing across the full spectrum. To gauge its performance, the Trust benchmarks its portfolio against the S&P 500 Index, the S&P 500 Consumer Staples Index, and the S&P 500 Health Care Index. Formed on February 20, 2007, The Gabelli Healthcare & Wellness Trust is domiciled in the United States.

Headline News

Wed, 27 May 2026
Gabelli Healthcare & WellnessRx Trust Announces $0.17 Per Share Distribution for Second Quarter, Payable June 24, 2026 - geneonline.com

Sat, 23 May 2026
EBITDA per share of The Gabelli Healthcare & Wellness Trust – NYSE:GRX - TradingView

Wed, 13 May 2026
Gabelli Healthcare & WellnessRx Trust Declares Second Quarter Distribution of $0.17 Per Share - GlobeNewswire

Sat, 25 Apr 2026
Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital - 24/7 Wall St.

Fri, 17 Apr 2026
GRX’s 14-Year Dividend Streak Holds Firm as Rate Cuts Ease Leverage Costs - 24/7 Wall St.

Wed, 10 Dec 2025
Gabelli Healthcare & WellnessRx Trust To Go Ex-Dividend On December 12th, 2025 With 0.17 USD Dividend Per Share - Moomoo

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Financial Services
Industry:
Asset Management
Shares Out 15 (M)
Shares Float 0 (M)
Held by Insiders 1.7 (%)
Held by Institutions 40.9 (%)
Shares Short 7 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0.15
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 61.39
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0.17
Forward Dividend 0
Dividend Yield 1.8%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android